## Zydus Lifesciences Limited (ZYDUSLIFE) Stock Analysis

This report analyzes the provided data for Zydus Lifesciences Limited (ZYDUSLIFE) to determine whether it's a buy, sell, or hold.  The analysis is based solely on the provided data and does not consider external market factors or sentiment.

**1. Data Preprocessing:**

The provided data has been parsed and organized into the following sections:

**1.1 Company Profile:**

| Feature          | Value                               |
|-----------------|---------------------------------------|
| Symbol           | ZYDUSLIFE                           |
| Company Name     | Zydus Lifesciences Limited           |
| Industry         | Pharmaceuticals                      |
| ISIN             | INE010B01027                         |
| Listing Date     | 2000-04-18                           |


**1.2 Market Data:**

| Metric                | Value      |
|-----------------------|-------------|
| Last Price            | 971.55      |
| Change                | -14.05      |
| % Change              | -1.43%      |
| Previous Close        | 985.60      |
| Open                  | 990.10      |
| Close                 | 973.50      |
| VWAP                  | 981.85      |
| Week High             | 1324.30     |
| Week Low              | 648.15      |
| Sector PE             | 23.07       |
| Symbol PE             | 23.07       |
| Delivery to Traded % | 49.99%      |


**1.3 Pre-Open Market Data:**

The pre-open market showed a slight increase in price from the previous close, reaching 990.10.  However, this was not sustained in the regular trading session.

**1.4 Corporate Actions:**

| Ex-Date      | Purpose                               |
|--------------|----------------------------------------|
| 26-Jul-2024  | Dividend - Rs 3 Per Share             |
| 23-Feb-2024  | Buy Back                               |
| 28-Jul-2023  | Dividend - Rs 6 Per Share             |
| 28-Jul-2022  | Dividend - Rs 2.50 Per Share           |
| 01-Jun-2022  | Buyback                               |
| 28-Jul-2021  | Dividend - Rs 3.50 Per Share           |
| ...           | ... (Further historical data available)|


**1.5 Recent Announcements (Last 5):**

| Broadcast Date    | Subject                               |
|--------------------|---------------------------------------|
| 19-Dec-2024       | Press Release                         |
| 17-Dec-2024       | Updates                               |
| 17-Dec-2024       | Sale or disposal-XBRL                |
| 16-Dec-2024       | General Updates                       |
| 04-Dec-2024       | Loss/Duplicate-Share Certificate-XBRL |


**1.6 Financial Results (Last Five Quarters):**

| Quarter End     | Income     | Expenditure | Profit After Tax | EPS     |
|-----------------|------------|-------------|-------------------|---------|
| 30-Sep-2024     | 294,730    | 190,800     | 78,980           | 7.85    |
| 30-Jun-2024     | 426,680    | 203,330     | 170,080          | 16.90   |
| 31-Mar-2024     | 369,350    | 200,000     | 140,520          | 13.89   |
| 31-Dec-2023     | 247,810    | 190,380     | 45,040           | 4.45    |
| 30-Sep-2023     | 269,380    | 172,570     | 80,500           | 7.96    |


**1.7 Shareholding Patterns:**

Promoter holding has remained consistently at 74.98% over the last five quarters.  No significant changes are observed.


**1.8 Board Meetings:**  Recent board meetings focused on approving financial results and corporate actions.


**1.9 Key Management Personnel:**

(List of directors and their designations are available in the provided data but omitted here for brevity.  This information is readily accessible from the processed data.)


**1.10 Contact Information:**

(Registrar and company contact details are available in the provided data but omitted here for brevity. This information is readily accessible from the processed data.)


**2. Key Indicators:**

**2.1 Current Price Analysis:**

* The current price (971.55) is below the previous close (985.60), indicating a downward trend.
* It's significantly below the week high (1324.30) and above the week low (648.15).
* The pre-open price (990.10) was higher than the closing price, suggesting selling pressure during the regular trading session.

**2.2 Financial Performance:**

* Revenue shows some fluctuation but generally positive growth over the last five quarters.
* Profitability is inconsistent, with significant variations in profit after tax across quarters.
* EPS also shows volatility, with a high of 16.90 and a low of 4.45.

**2.3 Shareholding Analysis:**

* Promoter holding remains stable at 74.98%, indicating strong insider confidence.

**2.4 Corporate Action Summary:**

* Recent dividends and buybacks suggest a return of capital to shareholders.

**2.5 Volatility and Risk:**

* The week high and low show significant price volatility.  The provided CM Annual Volatility (30.95%) further confirms this.

**2.6 Key Directors and Contact Info:**

(Refer to section 1.9 and 1.10)


**3. Final Verdict:**

**Hold.**

**Reasoning:**

While the company shows some positive revenue growth and consistent promoter holding, the significant price volatility, inconsistent profitability, and fluctuating EPS raise concerns.  The recent downward price movement and the fact that the pre-open price was not sustained also contribute to this recommendation.  More data and a clearer trend in profitability are needed before considering a buy recommendation.  The high volatility suggests a higher risk profile.


**Conclusion:**

Based on the provided data, Zydus Lifesciences Limited presents a mixed picture.  While the promoter holding is strong and there have been shareholder returns through dividends and buybacks, the financial performance and price volatility warrant a cautious approach.  A "hold" recommendation is advised until further data clarifies the trends and reduces the risk.
